![Alexander K. Andrianov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexander K. Andrianov
No open positions remaining
Profile
Alexander K.
Andrianov was the founder of Parallel Solutions, Inc. which was founded in 2001, where he held the title of Chief Scientific Officer in 2006.
Dr. Andrianov is also the founder of Neuimmune, Inc. Dr. Andrianov's former jobs include Director-Polymer Synthesis & Formulation at Celldex Therapeutics, Inc. and Vice President-Research & Development at Apogee Technology, Inc. Dr. Andrianov received a doctorate degree from Moscow State University Lomonosov in 1985.
Former positions of Alexander K. Andrianov
| Companies | Position | End |
|---|---|---|
Parallel Solutions, Inc.
 Parallel Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of polyphosphazene polymers | Founder | 01/01/2006 |
Neuimmune, Inc.
 Neuimmune, Inc. BiotechnologyHealth Technology Develops vaccines and biopharmaceuticals | Founder | - |
| CELLDEX THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Apogee Technology, Inc.
 Apogee Technology, Inc. Medical SpecialtiesHealth Technology Develops intradermal drug delivery systems for vaccines and other pharmaceuticals | Chief Tech/Sci/R&D Officer | - |
Training of Alexander K. Andrianov
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
90
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Apogee Technology, Inc.
Apogee Technology, Inc. Medical SpecialtiesHealth Technology Develops intradermal drug delivery systems for vaccines and other pharmaceuticals | Health Technology |
Parallel Solutions, Inc.
Parallel Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of polyphosphazene polymers | Commercial Services |
Moscow State University Lomonosov
 Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Neuimmune, Inc.
Neuimmune, Inc. BiotechnologyHealth Technology Develops vaccines and biopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Alexander K. Andrianov
